UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Cellivery sure to win licensing deal with top pharma company
by Jeong Sae-im
2020-05-07 11:27
Theragen Bio starts as independent company
by Shim Hyun-tai
2020-05-06 17:24
Kolon begins testing gene therapy for neuropathic pain in US
by Jeong Sae-im
2020-04-27 16:18
Pharmicell’s sales to rise with commercial supply of mPEG
by Shim Hyun-tai
2020-04-24 18:10
Herzuma wins 40% of market share in Japan
by Shim Hyun-tai
2020-04-21 16:42
라인
‘Stem cell therapy more effective on Covid-19’
by Jeong Sae-im
2020-04-21 11:01
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’
by Jeong Sae-im
2020-04-17 16:07
Samsung Bioepis launches anticancer biosimilar in US
by Shim Hyun-tai
2020-04-16 17:32
What are the odds for successful Invossa trials in US?
by Jeong Sae-im
2020-04-14 15:01
Celltrion gets antibody candidates neutralizing new coronavirus
by Shim Hyun-tai
2020-04-13 18:16
라인
FDA OKs resumption of phase-3 Invossa trial in US
by Jeong Sae-im
2020-04-13 11:58
Samsung signs contract with Vir to make COVID-19 treatment
by Shim Hyun-tai
2020-04-10 18:07
No Korean firms have entered trials to test COVID-19 drug candidates
by Jeong Sae-im
2020-04-08 16:15
Samsung Biologics signs CDO contract with PharmAbcine
by Shim Hyun-tai
2020-04-06 18:00
AbClon draws many new human antibodies to fight COVID-19
by Shim Hyun-tai
2020-03-30 17:47
라인
ImmuneMed under fire for inflating drug’s effect against COVID-19
by Jeong Sae-im
2020-03-27 11:49
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin
by Jeong Sae-im
2020-03-25 14:09
Will next-generation COVID-19 tests replace standard PCR checks?
by Jeong Sae-im
2020-03-25 11:40
KoBioLabs' allergic immune disease treatment enters global clinical trial
by Shim Hyun-tai
2020-03-23 16:03
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod
by Lee Han-soo
2020-03-20 16:52
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top